These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9915033)

  • 1. Hepatitis B immunization programme: Spain.
    de la Torre J
    Vaccine; 1998 Nov; 16 Suppl():S43-4. PubMed ID: 9915033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing universal vaccination programmes: Spain.
    de la Torre J; Esteban R
    Vaccine; 1995; 13 Suppl 1():S72-4. PubMed ID: 7571839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Universal hepatitis B immunization: young adolescent immunization.
    Tepper ML
    Vaccine; 1998 Nov; 16 Suppl():S23-6. PubMed ID: 9915028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of immigration and vaccination in reducing the incidence of hepatitis B in Catalonia (Spain).
    Oviedo M; Muñoz MP; Carmona G; Borrás E; Batalla J; Soldevila N; Domínguez A
    BMC Public Health; 2012 Aug; 12(1):614. PubMed ID: 22867276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaccination against hepatitis B. Impact of vaccination programmes after 20 years of use in Spain. Is it time for a change?].
    Arístegui Fernández J; Díez-Domingo J; Marés Bermúdez J; Martinón Torres F
    Enferm Infecc Microbiol Clin; 2015 Feb; 33(2):113-8. PubMed ID: 25620127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status of hepatitis B immunization programmes in 1998.
    Kane MA
    Vaccine; 1998 Nov; 16 Suppl():S104-8. PubMed ID: 9915049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects for vaccination against hepatitis A and B in Catalonia (Spain).
    Salleras L; Bruguera M; Buti M; Domíngez A
    Vaccine; 2000 Feb; 18 Suppl 1():S80-2. PubMed ID: 10683557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Success stories in the implementation of universal hepatitis B vaccination: an update on Italy.
    Bonanni P; Crovari P
    Vaccine; 1998 Nov; 16 Suppl():S38-42. PubMed ID: 9915032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Cannes 1993 to the present.
    Van Damme P; Verwimp G
    Vaccine; 1998 Nov; 16 Suppl():S3-6. PubMed ID: 9915024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Universal hepatitis B immunization: infant, and infant plus adolescent immunization.
    Bonanni P
    Vaccine; 1998 Nov; 16 Suppl():S17-22. PubMed ID: 9915027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update after 16 years of hepatitis B vaccination in South Africa.
    Burnett RJ; Kramvis A; Dochez C; Meheus A
    Vaccine; 2012 Sep; 30 Suppl 3():C45-51. PubMed ID: 22939021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in vaccination towards hepatitis B control and elimination in the Region of the Americas.
    Ropero Álvarez AM; Pérez-Vilar S; Pacis-Tirso C; Contreras M; El Omeiri N; Ruiz-Matus C; Velandia-González M
    BMC Public Health; 2017 Apr; 17(1):325. PubMed ID: 28415981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of hepatitis B markers in the population of Catalonia (Spain). Rationale for universal vaccination of adolescents.
    Salleras L; Bruguera M; Vidal J; Taberner JL; Plans P; Bayas JM; Pumarola T; Jimenez de Anta MT; Rodés J
    Eur J Epidemiol; 1992 Sep; 8(5):640-4. PubMed ID: 1426162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination of acute hepatitis B among adolescents after one decade of an immunization program targeting Grade 6 students.
    Patrick DM; Bigham M; Ng H; White R; Tweed A; Skowronski DM
    Pediatr Infect Dis J; 2003 Oct; 22(10):874-7. PubMed ID: 14551487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization.
    Chongsrisawat V; Yoocharoen P; Theamboonlers A; Tharmaphornpilas P; Warinsathien P; Sinlaparatsamee S; Paupunwatana S; Chaiear K; Khwanjaipanich S; Poovorawan Y
    Trop Med Int Health; 2006 Oct; 11(10):1496-502. PubMed ID: 17002723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public vaccination programmes against hepatitis B in The Netherlands: assessing whether a targeted or a universal approach is appropriate.
    Houweling H; Wittevrongel CF; Verweij M; Ruitenberg EJ;
    Vaccine; 2010 Nov; 28(49):7723-30. PubMed ID: 20933042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From hepatitis B to hepatitis A and B prevention: the Puglia (Italy) experience.
    Germinario C; Lopalco PL; Chirona M; Da Villa G
    Vaccine; 2000 Feb; 18 Suppl 1():S83-5. PubMed ID: 10683558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continue to vaccinate against hepatitis B.
    Prescrire Int; 2009 Jun; 18(101):131. PubMed ID: 19637437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B immunisation programmes in European Union, Norway and Iceland: where we were in 2009?
    Mereckiene J; Cotter S; Lopalco P; D'Ancona F; Levy-Bruhl D; Giambi C; Johansen K; Dematte L; Salmaso S; Stefanoff P; O'Flanagan D
    Vaccine; 2010 Jun; 28(28):4470-7. PubMed ID: 20451643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china.
    Zhao S; Xu Z; Lu Y
    Int J Epidemiol; 2000 Aug; 29(4):744-52. PubMed ID: 10922354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.